FDA Extends Trikafta Approval to Even Younger Cystic Fibrosis Patients
The FDA expanded the indication for elexacaftor, tezacaftor, and ivacaftor (Trikafta) in…
Browsing Tag
Fibrosis
Unhealthy Lifestyle Factors Into Idiopathic Pulmonary Fibrosis
Lifestyle habits may contribute to individual risk for idiopathic pulmonary fibrosis (IPF),…
New nanoparticles can perform gene-editing in the lungs: Using these RNA-delivery…
Engineers at MIT and the University of Massachusetts Medical School have designed a new type of nanoparticle that can be administered to the lungs, where it can deliver messenger RNA…
Integrated structural biology provides new clues for cystic fibrosis treatment
Scientists at St. Jude Children's Research Hospital and Rockefeller University have combined their expertise to gain a better understanding of the cystic fibrosis transmembrane conductance…
Black Patients Fare Worse With Deadly Lung Disease Pulmonary Fibrosis
Cara Murez
WEDNESDAY, March 15, 2023 (HealthDay News) -- Black patients are dying of pulmonary fibrosis, a devastating disease marked by progressive…
Diagnosis, Death in Pulmonary Fibrosis Seen Earlier in Black Patients
Black patients with pulmonary fibrosis (PF) consistently experienced poor outcomes…
Intercept Announces FDA Advisory Committee Meeting Date for Obeticholic Acid as a…
<!-- Name:DistributionId Value:8785947 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
BiomX Announces Positive Results from Part 1 of the Phase 1b/2a Study Evaluating…
<!-- Name:DistributionId Value:8754146 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Krystal Biotech Receives European Commission Orphan Designation for KB407 for the…
PITTSBURGH, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a biotechnology company focused on developing and commercializing genetic medicines for…
Intercept Announces Efficacy and Safety Data from Phase 3 REGENERATE Study in Liver…
MORRISTOWN, N.J., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company focused on the development and commercialization of novel…